NGF-inducing peptides
Nerve growth factor (NGF) is BDNF's older cousin. It sits alongside BDNF in the neurotrophin family, uses a related receptor system (TrkA rather than TrkB), and is particularly critical to the survival and function of cholinergic neurons in the basal forebrain — the same neuronal population that degenerates preferentially in Alzheimer's disease. Peptides that induce NGF as well as BDNF have a distinctive cognitive-relevance profile that the pure-BDNF-inducer family does not.
The molecular difference
NGF versus BDNF — the same family, different targets
NGF and BDNF are both members of the neurotrophin family — small secreted proteins that support the survival, development, and function of specific neuronal populations. They share a common evolutionary origin and a common receptor-family architecture, but they target different neurons and support different aspects of cognitive function.
BDNF binds TrkB receptors that are widely expressed across the hippocampus and cortex. It supports activity-dependent synaptic plasticity — the cellular substrate of learning and memory. This is why the BDNF-induction endpoint dominates the cognitive-enhancement peptide literature.
NGF binds TrkA receptors that are highly enriched on cholinergic neurons in the basal forebrain. Cholinergic tone supports attention, arousal, and the general cognitive-context state that memory operates within. Cholinergic-neuron degeneration is one of the earliest and most severe pathologies of Alzheimer's disease, which is why the cholinergic hypothesis of AD dominated the field for decades. Peptides that induce NGF specifically — Semax, Selank, Noopept, Cerebrolysin, N-Acetyl Semax — engage this distinctive cholinergic-support angle.
The family
Peptides that induce NGF
Semax
A synthetic heptapeptide analogue of ACTH(4-10) developed in Russia for cognitive enhancement, neuroprotection, and stroke recovery research.
Cerebrolysin
A complex mixture of low-molecular-weight peptides and free amino acids derived from porcine brain tissue, studied extensively in cognitive decline and post-stroke recovery research.
Noopept (Peptide Note)
A small proline-containing dipeptide derivative — technically a peptidomimetic — developed in Russia as an orally active cognitive enhancer with structural lineage to piracetam.
N-Acetyl Semax Amidate
A chemically protected analogue of Semax with N-terminal acetylation and C-terminal amidation, conferring substantially extended half-life and improved potency in research.
Cycloprolylglycine
An endogenous cyclic dipeptide that is also the primary active metabolite of Noopept, with intrinsic anxiolytic and cognitive effects independent of its parent compound — a research peptide in its own right.
Org 2766
A classical Dutch/Organon ACTH(4-9) analogue closely related to Semax — the direct pharmacological cousin of the Russian cognitive-peptide programme's flagship compound, with independent memory and neuroprotective research history.
Why this cluster matters